Clinical Trial

Phase III Clinical Study of VC005 in Adult and Adolescents With Mild to Moderate Atopic Dermatitis

Name: Phase III Clinical Study of VC005 in Adult and Adolescents With Mild to Moderate Atopic Dermatitis — clinical trial record (NCT07592585)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

A multicenter, randomized, double-blind, vehicle controlled phase III clinical study to evaluate the efficacy and safety of VC005 in adults and adolescents with mild to moderate atopic dermatitis

Protocol Amendment History 1 change

critical Recruitment opened 2026-07-08

Trial Details

NCT Number	NCT07592585
Lead Sponsor	Jiangsu vcare pharmaceutical technology co., LTD
Conditions	Atopic Dermatitis
Enrollment	360 participants
Start Date	2026-05-12
Primary Completion	2028-05-30 (estimated)
Study Completion	2028-05-30 (estimated)
Updated on ClinicalTrials.gov	2026-07-07